[
  {
    "ts": "2025-11-08T04:06:54+00:00",
    "headline": "Jim Cramer on Amgen: “They Have A Lot of Good Medicines”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer recently shared thoughts on. Cramer said that the company needs to “broaden the portfolio,” as he remarked: “Look, I think Amgen needs to do something because they’ve gotta broaden the portfolio where they need to be able to tell a little bit better story about […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-amgen-lot-good-040654431.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "052d01c7-3ec8-36cf-9454-c47959e0efdb",
      "content": {
        "id": "052d01c7-3ec8-36cf-9454-c47959e0efdb",
        "contentType": "STORY",
        "title": "Jim Cramer on Amgen: “They Have A Lot of Good Medicines”",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer recently shared thoughts on. Cramer said that the company needs to “broaden the portfolio,” as he remarked: “Look, I think Amgen needs to do something because they’ve gotta broaden the portfolio where they need to be able to tell a little bit better story about […]",
        "pubDate": "2025-11-08T04:06:54Z",
        "displayTime": "2025-11-08T04:06:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66",
          "originalWidth": 1920,
          "originalHeight": 1282,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IdJAH7xlT5z0Usubd4WzNQ--~B/aD0xMjgyO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66.cf.webp",
              "width": 1920,
              "height": 1282,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NdySNIhfoJQSPxvzs_Yikg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-lot-good-040654431.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-lot-good-040654431.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]